One-year Real-world Outcomes With Faricimab in Neovascular Age-related Macular Degeneration

20260 citationsJournal Article

Authors

David C. Tabano

Ferhina S. Ali · New York Medical College

Durga Borkar · Duke University

Theodore Leng · Smith-Kettlewell Eye Research Institute

Amanda Downey · Roche (Canada)

Abstract

Outcomes among patients with nAMD receiving faricimab over 1-year follow-up support the real-world effectiveness and extended durability of treatment.

Topics & Keywords

Retinal Diseases and Treatments Ophthalmology and Visual Impairment Studies Ocular Diseases and Behçet’s Syndrome

Publication Details

Published in: Ophthalmic surgery, lasers & imaging retina

DOI: 10.3928/23258160-20260302-02

Field-Weighted Citation Impact: 0.00

Command Palette

One-year Real-world Outcomes With Faricimab in Neovascular Age-related Macular Degeneration

Authors

Abstract

Topics & Keywords

Publication Details